Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03865342
Other study ID # 695755-6
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2016
Est. completion date June 25, 2018

Study information

Verified date April 2023
Source Noom Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will test the weight loss efficacy of a mobile diabetes prevention program intervention. Half of the sample of prediabetic adults will receive the virtual DPP and half will receive usual medical care.


Description:

There were 84.1 million people with pre-diabetes, 30.3 million people with diagnosed and 7.2 million with undiagnosed diabetes in the United States in 2015, and nearly 2 million are diagnosed with it every year. By 2050, the CDC estimates that 1 in every 3 people globally will have diabetes, a leading cause of death and disability. The primary goal of this study is to evaluate the efficacy of the Noom Coach Diabetes Prevention Program mobile platform versus usual medical care. The best intervention to date for prediabetes is the Centers for Disease Control and Prevention's Diabetes Prevention Program, yet there is limited research investigating a mobile-based delivery of the DPP. Pre-diabetes is often discovered during routine medical visitation/annual screening (usual care), but face-to-face time with clinicians is often limited. Exploring novel ways, such as mHealth interventions to empower patients to pursue lifestyle change and prevent or delay diabetes onset is critical to addressing the growing diabetes epidemic.


Recruitment information / eligibility

Status Completed
Enrollment 202
Est. completion date June 25, 2018
Est. primary completion date June 25, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - English-speaking - 18 years of age and older - Referral from the patient's physician - Hemoglobin A1C: 5.7 - 6.4 within the 3 months prior to enrollment - Own a smartphone (Apple or Android) Exclusion criteria: - Recent weight loss (by patient report, >5 lbs in the 6 months preceding enrollment visit) - previous diagnosis of type 1 or type 2 diabetes - serious or persistent mental illnesses - more than 72 hours of hospitalization in the last 30 days - Enrollment in a structured weight-loss program currently or within the 1 month preceding study enrollment - Pregnant - Currently nursing - Have given birth within the past 3 months - Has been discouraged by a physician to enroll in a DPP program

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Noom Coach DPP
Subjects receiving the smartphone app will receive the DPP core curriculum for 16 weeks and then the post-core curriculum for 36 weeks through the app. The Noom mobile app allows secure patient monitoring through a participant dashboard that the coach can use to increase patient adherence and motivation to achieve DPP goals. The participant can log their food intake, weight, steps, exercise, in addition to participating in the DPP group interaction through the application.

Locations

Country Name City State
United States Stony Brook University Stony Brook New York

Sponsors (2)

Lead Sponsor Collaborator
Noom Inc. Stony Brook University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in work productivity Work Productivity and Activity Impairment Questionnaire: General Health V2.0 (WPAI)
Are you currently employed (working for pay)?
During the past seven days, how many hours did you miss from work because of your health problems?
During the past seven days, how many hours did you miss from work because of any other reason, such as vacation, holidays, time off to participate in this study?
During the past seven days, how many hours did you actually work?
During the past seven days, how much did your health problems affect your productivity while you were working? (0-10, higher is more impact)
During the past seven days, how much did your health problems affect your ability to do your regular daily activities, other than work at a job? By regular activities, we mean the usual activities you do, such as work around the house, shopping, childcare, exercising, studying, etc.(0-10, higher is more impact)
Baseline, 6, and 12 months
Other Change in quality of life Healthy Days Core Module (CDC HRQOL- 4)
Would you say that in general your health is excellent, very good, good, fair or poor? Excellent Good Fair Poor
Now thinking about your physical health, which includes physical illness and injury, how many days during the past 30 days was your physical health not good?
Now thinking about your mental health, which includes stress, depression, and problems with emotions, how many days during the past 30 days was your mental health not good?
During the past 30 days, approximately how many days did poor physical or mental health keep you from doing your usual activities, such as self-care, work, or recreation?
Baseline, 6, and 12 months
Primary Change in weight Body weight recorded during follow-up appointments at the medical clinic. Baseline, 6, and 12 months
Secondary Change in hemoglobin A1c Hemoglobin A1c measured during follow-up appointments at the medical clinic. Baseline, 6, and 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Completed NCT03188263 - Morning Light Treatment to Improve Glucose Metabolism N/A
Recruiting NCT03821961 - 18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery N/A
Completed NCT04303468 - Intervention With a GABA Supplement in Prediabetics N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Completed NCT01910051 - Explorative Assessment of Biomarkers in Overweight and Obese Subjects
Completed NCT03527368 - The Time-Restricted Intake of Meals Study N/A
Suspended NCT03240978 - Exercise Intervention for the Prevention of Prediabetes in Overweight Chinese N/A
Completed NCT02899390 - Diabetes Prevention Program in Adults of the Yaqui Tribe of Hermosillo, Sonora at Risk of Diabetes N/A
Recruiting NCT01972113 - Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study) N/A
Completed NCT01432509 - Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord) N/A
Completed NCT01436916 - Oral Cholecalciferol in Prevention of Type 2 Diabetes Mellitus Phase 4
Completed NCT00990184 - Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes) Phase 3
Completed NCT00886340 - A Lifestyle Change Program to Prevent Type 2 Diabetes Phase 2
Not yet recruiting NCT05658770 - Efficacy of Physical Exercise on Glucose Control in People With Prediabetes (GLYCEX) - Phase II N/A
Recruiting NCT05681468 - Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources N/A